Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	236.64	39.86	11.84
Graham Fair Price	-0.63	34054.84	34271.31
PEG	6590.12	-0.69	0.01
Price/Book	-5.41	0.34	0.36
Price/Cash Flow	22.20	37.26	30.50
Prices/Earnings	3.27	3.36	3.25
Price/Sales	26.12	5.36	4.25
Price/FCF	22.20	37.26	30.50
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	-50.88	0.21	0.43
Operating Margin	-68.04	0.12	0.36
ROA	-7.89	0.02	0.02
ROE	0.03	0.03	-8.40
ROIC	0.03	< 0.005	-85.54
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	0.18	-0.04	301.95
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	3.34	-0.75	-77.50
EPS QOQ	3.17	-0.05	-98.46
FCF QOQ	5.10	-0.20	-96.15
Revenue QOQ	0.31	-0.22	-28.04
Naive Interpretation	member

03 - Financial Growth · Bad

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	85.86	80.20	-6.60
Days Sales Outstanding (DSO)	78.15	96.69	23.72
Inventory Turnover	1.05	1.12	7.06
Debt/Capitalization	0.07	0.08	12.10
Quick Ratio	1.09	1.15	4.86
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	43348.18	45006.32	3.83
Cash	2868.21	3175.10	10.70
Capex	-30.27	47.79	57.89
Free Cash Flow	513.19	412.46	-19.63
Revenue	3681.17	2866.53	-22.13
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	1.47	1.51	3.06
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	0.80	3.38	324.76
Naive Interpretation	Member

06 - Financial Health · Weak

Rating